Viewing Study NCT01271803


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2026-01-02 @ 8:43 AM
Study NCT ID: NCT01271803
Status: COMPLETED
Last Update Posted: 2019-07-29
First Post: 2011-01-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma
Sponsor: Hoffmann-La Roche
Organization: